The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

HealthSouth Corp

NYSE: HLS
Last

(U.S.) $31.62

Today's change-1.52 -4.59%
Updated February 11 2:19 PM EST. Delayed by at least 15 minutes.
 

HealthSouth Corp

NYSE: HLS
Last

(U.S.) $31.62

Today's change-1.52 -4.59%
Updated February 11 2:19 PM EST. Delayed by at least 15 minutes.

HealthSouth Corp down (U.S.)$1.52

HealthSouth Corp is sharply lower today, dropping (U.S.)$1.52 or 4.59% to (U.S.)$31.62. Over the last five days, shares have lost 13.01% and are down 9.16% for the last year to date. This security has underperformed the S&P 500 by 17.14% during the last year.

Key company metrics

  • Open(U.S.) $32.43
  • Previous close(U.S.) $33.14
  • High(U.S.) $32.89
  • Low(U.S.) $31.56
  • Bid / Ask(U.S.) $31.60 / (U.S.) $31.63
  • YTD % change-9.16%
  • Volume699,913
  • Average volume (10-day)655,969
  • Average volume (1-month)705,248
  • Average volume (3-month)716,944
  • 52-week range(U.S.) $31.56 to (U.S.) $48.37
  • Beta1.36
  • Trailing P/E18.07×
  • P/E 1 year forward15.16×
  • Forward PEG1.48×
  • Indicated annual dividend(U.S.) $0.92
  • Dividend yield2.91%
  • Trailing EPS(U.S.) $1.75
Updated February 11 2:19 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+8.52%

Based on its net profit margin of 8.52%, HealthSouth Corp is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX1.43%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue768754729607
Total other revenue--------
Total revenue768754729607
Gross profit737722698577
Total cost of revenue31323130
Total operating expense632634610510
Selling / general / administrative461447434349
Research & development--------
Depreciation / amortization34333228
Interest expense (income), net operating--------
Unusual expense (income)019912
Other operating expenses, total10710410391
Operating income13612011997
Interest income (expense), net non-operating-36-31-32-26
Gain (loss) on sale of assets--------
Other--------
Income before tax103949074
Income after tax68625955
Income tax, total36323019
Net income51434342
Total adjustments to net income00-2-2
Net income before extra. items50454339
Minority interest-17-17-17-15
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items50444138
Inc. avail. to common incl. extra. items50434140
Diluted net income51434144
Dilution adjustment0----4
Diluted weighted average shares102102101101
Diluted EPS excluding extraordinary itemsvalue per share0.500.440.400.41
Dividends per sharevalue per share0.230.210.210.21
Diluted normalized EPSvalue per share0.500.560.450.50